SIRP alphaV2

SIRP alphaV2

SIRP alphaV2 詳細

Molecule Name
Signal-regulatory protein alpha
分子の別称
SHPS1,SIRPA,CD172A,BIT,MFR,MYD1,P84,PTPNS1
Drug Development Progress
治験薬の数19
市販薬剤の数2
研究&開発段階Approved
ターゲットの別称
SHPS-1,Macrophage fusion receptor,Brain Ig-like molecule with tyrosine-based activation motifs,MFR,Signal-regulatory protein alpha-1,Signal-regulatory protein alpha-2,CD172a,MyD-1 antigen,Sirp-alpha-3,MYD1,SIRPA,Signal Regulatory Protein Alpha,CD172 Antigen-Like Family Member A,Inhibitory Receptor SHPS-1,PTPNS1,SHPS1,SIRP,P84,Brain-Immunoglobulin-Like Molecule With Tyrosine-Based Activation Motifs,Protein Tyrosine Phosphatase, Non-Receptor Type Substrate 1,Tyrosine-Protein Phosphatase Non-Receptor Type Substrate 1,Tyrosine Phosphatase SHP Substrate 1,Signal-Regulatory Protein Alpha-3,Signal-Regulatory Protein Alpha,SHP Substrate 1,CD172a Antigen,Sirp-Alpha-1,Sirp-Alpha-2,MYD-1,Bit,SIRPalpha,SIRPalpha2
バックグランド
Tyrosine-protein phosphatase non-receptor type substrate 1 (SHPS1) is also known as CD172 antigen-like family member A (CD172a), Macrophage fusion receptor, MyD-1 antigen, Signal-regulatory protein alpha (SIRPA or SIRP alpha) or p84, is a member of the SIRP family, and also belongs to the immunoglobulin superfamily. SIRP alpha is Ubiquitous and highly expressed in brain. SIRPA / CD172a is immunoglobulin-like cell surface receptor for CD47 and acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. SIRPA / SHPS-1 supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment and may play a key role in intracellular signaling during synaptogenesis and in synaptic function By similarity. SIRPA / MyD1 involved in the negative regulation of receptor tyrosine kinase-coupled cellular responses induced by cell adhesion, growth factors or insulin and mediates negative regulation of phagocytosis, mast cell activation and dendritic cell activation. CD47 binding prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells.

SIRP alphaV2 製品リスト

Species
  • Human(3)
Tag
  • His Tag(1)
  • His Tag & Avi Tag(1)
  • Llama IgG Fc Tag(1)
Host
  • HEK293(3)
Conjugate
  • Unconjugated(2)
  • Biotin-labeled(1)
Grade
  • RUO(3)
Low Endotoxin
  • Yes(2)
  • No(1)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
SIRP alphaV2
HOTAvitag
SI2-H82W8
Biotinylated Human SIRP alphaV2 / CD172a Protein, His,Avitag™
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
SIRP alphaV2
Human SIRP alphaV2 / CD172a Protein, His Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
SIRP alphaV2
Human SIRP alphaV2 / CD172a (31-148) Protein, Llama IgG2b Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$390.00

100ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
IpsoprubartELA-026Phase 3 ClinicalElectra Therapeutics Inc
Lymphohistiocytosis, Hemophagocytic; Neoplasms
詳細
LM-101LM-101Phase 2 ClinicalLaNova Medicines Ltd
Hematologic Neoplasms; Leukemia; Neoplasms; Solid tumours
詳細
HX-044HX044; HX-044Phase 2 ClinicalHanx Biopharmaceuticals Pty Ltd
Lymphoma; Solid tumours
詳細
BRB-002BRB-002Phase 2 ClinicalBitterroot Bio Inc
Atherosclerosis; Cardiovascular Diseases; Vasculitis
詳細
BI-770371BI-770371Phase 2 ClinicalOse Immunotherapeutics
Carcinoma, Non-Small-Cell Lung; Liver Cirrhosis; Melanoma; Metabolic Dysfunction-Associated Steatotic Liver Disease; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
IBC-0966IBC-0966Phase 2 Clinical
Neoplasms
詳細
HX-009HX-009; HX009-II-02Phase 2 ClinicalWaterstone Hanxbio Pty Ltd
Bile Duct Neoplasms; Biliary Tract Neoplasms; Liver Neoplasms; Lymphoma; Melanoma; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
詳細
BI-765063OSE-172; BI-765063; Effi-DEMPhase 1 ClinicalEffimune
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
ADU-1805ADU-1805Phase 1 ClinicalAduro Biotech Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Endometrial Neoplasms; Neoplasms; Solid tumours
詳細
Q-1801Q-1801; Q 1801Phase 1 ClinicalQure Biotechnology (Shanghai) Co Ltd
Solid tumours
詳細
Recombinant humanized IgG4 anti-SIRPα antibody(Daiichi Sankyo)DS-1103aPhase 1 ClinicalDaiichi Sankyo Co Ltd
Breast Neoplasms; Solid tumours
詳細
JY-47JY47; JY-47Phase 1 ClinicalHangzhou Jiuyuan Gene Biomedical Co Ltd
Liver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Solid tumours
詳細
BYON-4228BYON-4228Phase 1 ClinicalSanquin Blood Supply Foundation
Lymphoma; Solid tumours
詳細
BSI-082BSI-082Phase 1 ClinicalBiosion Inc
Hematologic Neoplasms; Neoplasm Metastasis; Solid tumours
詳細
BR-105BR-105; BR105Phase 1 ClinicalHisun Biopharmaceutical Co Ltd, Zhejiang BioRay Biopharmaceuticals Co Ltd
Lymphoma, Large B-Cell, Diffuse; Neoplasms
詳細
[89Zr]Zr- BI-765063(Boehringer Ingelheim)Phase 1 ClinicalBoehringer Ingelheim Corp
Carcinoma, Non-Small-Cell Lung; Melanoma; Squamous Cell Carcinoma of Head and Neck
詳細
TQB-2928TQB-2928Phase 1 ClinicalJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Carcinoma, Non-Small-Cell Lung; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms; Osteosarcoma; Solid tumours
詳細
BI-765080Phase 1 ClinicalC.H. Boehringer Sohn Ag & Co. Kg
詳細
ES-004ES-004; ES 004-N4; ES 004-B4Phase 1 ClinicalElpiscience (Shanghai) Biopharma Ltd
Neoplasms; Solid tumours
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Relugolix/Estradiol/Norethindrone AcetateE2/NETAApprovedMyovant SciencesMYFEMBREE, RYEQOUnited StatesMenorrhagia; LeiomyomaSumitomo Pharma America Inc, Myovant Sciences2021-05-26
Endometriosis; Leiomyoma; Menorrhagia; Pain; Uterine Neoplasms
詳細
Elagolix/estradiol/norethindrone acetateApprovedAbbvie IncOriahnnUnited StatesMenorrhagiaAbbvie Inc2020-05-29
Menorrhagia
詳細
Customer Reviews